Following Johnson & Johnson’s $2.2 billion settlement for off-label marketing and kickbacks related to its antipsychotic Risperdal, Pennsylvania legislators Brandon Neuman and Tony DeLuca are renewing their push for a Pennsylvania version of the False Claims Act. Whistleblowers in three states will collect $167.7 million under the federal False Claims Act, they say, while Pennsylvania remains the largest state in the union without such a law. “Pennsylvanians lose as much as $200 million a year through Medicare and Medicaid fraud and abuse,” according to Neuman, “Our Pennsylvania False Claims Act legislation … would go a long way toward deterring this dishonesty.”
What a great idea. I think every time news about cases like these reaches the public, it’s another step toward getting people to realize what fraud psychiatry is in general.
First 2 things I thought of after reading this:
One in six adolescents were taking antipsychotic medications by the end of a five-year study of 686,000 children in foster care in 48 states. Other psychoactive medication and the use of multiple simultaneous medications (“polypharmacy”) were declining by the end of the study. “We’re not saying these medications should never be used for children, but the high rate at which they’re used by children in foster care indicates that other interventions and supports, such as trauma-based counseling, may not be in place for them,” said one author.
NAMI – Pharmaceutical Front Group
Look on the internet archive , it goes back to 1996.
NAMI, the pharma front group, was marketing Risperdal for kids it has this link right on its home page.
“Risperidone for Adolescent Aggression”
Medical Focus, Winter 1996
I call this “Pharma Pedophilia” targeting children to make billions pushing drugs with fraud.
They make the billions and the kids get ****ed